|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Current assets: | |||
| Cash and cash equivalents | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Total current assets | |||
| Property and equipment, net | |||
| Total assets | |||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||
| Current liabilities: | |||
| Accounts payable | |||
| Promissory Note | |||
| Deferred revenue, current | |||
| Related party loan | |||
| Current portion of long-term debt | |||
| Accrued and other current liabilities | |||
| Total current liabilities | |||
| Long-term debt, net of current portion | |||
| Total liabilities | |||
| Convertible Preferred Stock, $0.0001 par value; 1,246,063 shares and 1,561,892 shares authorized, at June 30, 2026 and December 31, 2025, respectively, 821,796 and 1,237,717 shares issued and outstanding as of June 30, 2025 and December 31, 2025, respectively | |||
| Stockholders’ deficit | |||
| Series preferred stock, $0.0001 par value; 148,438,108 shares and 148,438,108 shares authorized, at June 30, 2026 and December 31, 2025, respectively, 14,651,864 and 17,494,820 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||
| Common stock, $0.0001 par value; 250,000,000 and 250,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 29,973,178 and 13,896,400 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||
| Additional paid in capital | |||
| Accumulated other comprehensive income | |||
| Accumulated deficit | |||
| Total stockholders’ deficit | |||
| Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit |
Loading...
